Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
G Bjelakovic, D Nikolova, LL Gluud… - Cochrane database …, 2012 - cochranelibrary.com
Antioxidant supplements for prevention of mortality in healthy participants and patients with
various diseases - Bjelakovic, G - 2012 | Cochrane Library Skip to Content Cookies Our site …
various diseases - Bjelakovic, G - 2012 | Cochrane Library Skip to Content Cookies Our site …
First‐line drugs for hypertension
JM Wright, VM Musini, R Gill - Cochrane Database of …, 2018 - cochranelibrary.com
Background This is the first update of a review published in 2009. Sustained moderate to
severe elevations in resting blood pressure leads to a critically important clinical question …
severe elevations in resting blood pressure leads to a critically important clinical question …
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
HC Gerstein, JFE Mann, Q Yi, B Zinman, SF Dinneen… - Jama, 2001 - jamanetwork.com
ContextMicroalbuminuria is a risk factor for cardiovascular (CV) events. The relationship
between the degree of albuminuria and CV risk is unclear. ObjectivesTo estimate the risk of …
between the degree of albuminuria and CV risk is unclear. ObjectivesTo estimate the risk of …
Edmund Dunstan
1 Patel A; ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and
indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes …
indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes …
Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
Heart Outcomes Prevention Evaluation … - … England Journal of …, 2000 - Mass Medical Soc
Background Angiotensin-converting–enzyme inhibitors improve the outcome among
patients with left ventricular dysfunction, whether or not they have heart failure. We assessed …
patients with left ventricular dysfunction, whether or not they have heart failure. We assessed …
Angiotensin-converting enzyme inhibitors
NJ Brown, DE Vaughan - Circulation, 1998 - Am Heart Assoc
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …
The association of microalbuminuria and mortality in non—insulin-dependent diabetes mellitus: a systematic overview of the literature
SF Dinneen, HC Gerstein - Archives of internal medicine, 1997 - jamanetwork.com
Objectives: To critically analyze the literature linking microalbuminuria with total and
cardiovascular mortality and cardiovascular morbidity in non—insulin—dependent diabetes …
cardiovascular mortality and cardiovascular morbidity in non—insulin—dependent diabetes …
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
S Taddei, A Virdis, L Ghiadoni, A Magagna, A Salvetti - Circulation, 1998 - Am Heart Assoc
Background—Essential hypertension is associated with impaired endothelium-dependent
vasodilation. Inactivation of endothelium-derived nitric oxide by oxygen free radicals …
vasodilation. Inactivation of endothelium-derived nitric oxide by oxygen free radicals …
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial
Background The level to which systolic blood pressure should be controlled in hypertensive
patients without diabetes remains unknown. We tested the hypothesis that tight control …
patients without diabetes remains unknown. We tested the hypothesis that tight control …
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
Background Electrocardiographic markers of left ventricular hypertrophy (LVH) predict poor
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …